Even though managing cholesterol can be a very important task, one when doctors likely step in by prescribing statins like Lipitor, there are side effect risks (like with any drug). The trouble is determining how likely those side effects are, and proactive patients don’t always know how to assess that without some serious direction. Some […]
Watson Pharmaceuticals’ (NYSE:WPI) strategy for launching its generic version of Lipitor was the topic of conversation in its third-quarter results as Pfizer’s (NYSE:PFE) exclusive patent to the cholesterol drug nears its expiration date. During Watson’s conference call to discuss its quarterly earnings, CEO Paul Bisaro said: “Regarding the launch of generic Lipitor later this month, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Lipitor, Pfizer’s (NYSE: PFE) best-selling drug, could be the first of the statins brought to the over-the-counter market when the company’s patent on it ends Nov. 30, according to Business Week. The news magazine cited comments made by Pfizer’s CEO Ian Read in a conference call discussing the pharmaceutical company’s third-quarter earnings. Pfizer CEO Ian […]